Lepu Xintai Medical submits a prospectus to the Hong Kong Stock Exchange

Lepu Xintai Medical is committed to providing safe, effective and innovative medical solutions. It is a pioneer in China’s structural heart disease interventional medical device industry and a large domestic supplier of congenital heart disease occlusion devices. Today, Lepu Xintai Medical submitted its prospectus to the Hong Kong Stock Exchange.

This article is reprinted from: https://www.itjuzi.com/pre-ipo?comname=%E4%B9%90%E6%99%AE%E5%BF%83%E6%B3%B0%E5%8C%BB% E7%96%97
This site is for inclusion only, and the copyright belongs to the original author.